Amgen Inc. (NASDAQ:AMGN) is one of the best stem cell therapy stocks to buy. Canaccord initiated coverage of Amgen Inc.

If you are wondering whether Amgen’s recent share price puts it on sale or at a premium, and what that really means for your ...

View Amgen Inc. AMGN stock quote prices, financial information, real-time forecasts, and company news from CNN.

Amgen (AMGN) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Over ...

Amgen Inc. (NASDAQ:AMGN) is one of Jim Cramer’s Hottest GLP-1 and Weight Loss Stock Picks. Amgen Inc. (NASDAQ:AMGN) is one of the largest drug companies in the world. The firm is currently developing ...

In its upcoming report, Amgen (AMGN) is predicted by Wall Street analysts to post quarterly earnings of $4.73 per share, reflecting a decline of 3.5% compared to the same period last year. Revenues ...

Looking ahead to 2030, our model projects AMGN could trade at an average price of $537.89, with a potential range between $403.41 and $672.36. This represents a potential 57.0% return from today's ...

The weight-loss market has become one of the most active therapeutic areas in the pharmaceutical industry over the past few years. And based on analyst projections, it will continue growing at a good ...

On April 13, UBS lifted its price recommendation on Amgen Inc. (NASDAQ:AMGN) to $400 from $390. It reiterated a Buy rating on ...